| Literature DB >> 28618135 |
Zhan-Yi Sun1, Pu-Guang Chen1, Yan-Fang Liu1, Lei Shi1, Bo-Dou Zhang1, Jun-Jun Wu1, Yu-Fen Zhao1, Yong-Xiang Chen1, Yan-Mei Li1.
Abstract
Immunotherapy has become one of the most promising therapies for the treatment of diseases. Synthetic immunostimulants and nanomaterial immunostimulant systems are indispensable for the activation of the immune system in cancer immunotherapy. Herein, a strategy for preparing self-assembled nano-immunostimulants (SANIs) for synergistic immune activation is reported. Three immunostimulants self-assemble into nanoparticles through electrostatic interactions. SANIs showed strong synergistic immunostimulation in macrophages. SANIs could also induce a strong antitumor immune response to inhibit tumor growth in mice and act as an efficient adjuvant of antitumor vaccines. Therefore, SANIs may be generally applied in cancer immunotherapy. This novel SANI strategy provides a new way for the development of both immunostimulants and -suppressants.Entities:
Keywords: antibodies; cancer; immunochemistry; nanoparticles; self-assembly
Mesh:
Substances:
Year: 2017 PMID: 28618135 DOI: 10.1002/cbic.201700246
Source DB: PubMed Journal: Chembiochem ISSN: 1439-4227 Impact factor: 3.164